MedPath

Selenium Sulfide

Selenium Sulfide 2.3% Shampoo

Approved
Approval ID

4414584a-d706-4164-a33a-e1b3bfacc9cf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 1, 2021

Manufacturers
FDA

Cameron Pharmaceuticals, LLC

DUNS: 078371442

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Selenium Sulfide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42494-336
Product Classification
G
Generic Name
Selenium Sulfide
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 1, 2021
FDA Product Classification

INGREDIENTS (24)

TRICAPRINInactive
Code: O1PB8EU98M
Classification: IACT
SELENIUM SULFIDEActive
Quantity: 23 mg in 1 mL
Code: Z69D9E381Q
Classification: ACTIB
CHROMIC OXIDEInactive
Code: X5Z09SU859
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
COCAMIDOPROPYL BETAINEInactive
Code: 5OCF3O11KX
Classification: IACT
FLUORESCEIN SODIUMInactive
Code: 93X55PE38X
Classification: IACT
DIAZOLIDINYL UREAInactive
Code: H5RIZ3MPW4
Classification: IACT
PANTHENOLInactive
Code: WV9CM0O67Z
Classification: IACT
DISTEARYL PHTHALAMIC ACIDInactive
Code: 5552GSZ9LI
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NC
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PPG-2 HYDROXYETHYL COCO/ISOSTEARAMIDEInactive
Code: EK4J71ZKEQ
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
UREAInactive
Code: 8W8T17847W
Classification: IACT
PYRITHIONE ZINCInactive
Code: R953O2RHZ5
Classification: IACT
AMMONIUM LAURYL SULFATEInactive
Code: Q7AO2R1M0B
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/1/2021

Principal Display Panel - 180 mL Bottle Carton

NDC 42494-336-06

​Selenium Sulfide 2.3% Shampoo

​FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE

Cameron Pharmaceuticals™

Net wt. 6 fl. oz. (180 mL)

bottle

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 4/1/2021

​INDICATIONS:

Selenium Sulfide 2.3% Shampoo is a liquid antiseborrheic, antifungal preparation useful for the treatment of seborrheic dermatitis of the scalp, dandruff and tinea versicolor. Urea hydrates and is useful for conditions such as dry scalp.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 4/1/2021

CONTRAINDICATIONS:

Selenium Sulfide 2.3% Shampoo is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 4/1/2021

ADVERSE REACTIONS:

In decreasing order of severity: skin irritation; occasional reports of increase in normal hair loss; discoloration of hair (can be avoided or minimized by thorough rinsing of hair after treatment). As with other shampoos, oiliness or dryness of hair and scalp may occur.

Call your licensed medical practitioner for medical advice about side effects. To report a serious adverse event, call 1-888-767-7913.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 4/1/2021

KEEP OUT OF REACH OF CHILDREN

Rx only

Manufactured for:

Cameron Pharmaceuticals, LLC 1009 Twilight Trail

Frankfort, Kentucky 40601

Rev. 08/2015

DESCRIPTION SECTION

LOINC: 34089-3Updated: 4/1/2021

​DESCRIPTION:

Each mL contains 23 mg of selenium sulfide in a vehicle consisting of: ammonium lauryl sulfate, caprylic/capric triglyceride, chromium oxide green, citric acid, cocamidopropyl betaine, D&C yellow no 8, diazolidinyl urea, distearyl phthalic acid amide, edetate disodium, fragrance, hydroxypropyl methylcellulose, magnesium aluminum silicate, methylparaben, panthenol, PPG-2 hydroxyethyl coco/isostearamide, propylene glycol, propylparaben, purified water, FD&C red no 40, sodium citrate, titanium dioxide, tocopheryl acetate, urea, and zinc pyrithione.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 4/1/2021

CLINICAL PHARMACOLOGY:

Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, reducing corneocyte production.

​Pharmacokinetics:

The mechanism of action of topically applied selenium sulfide is not yet known.

WARNINGS SECTION

LOINC: 34071-1Updated: 4/1/2021

WARNINGS:

PRECAUTIONS: FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Avoid contact with eyes, lips and mucous membranes.

General:

Selenium Sulfide 2.3% Shampoo is to be used as directed by a licensed medical practitioner and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a licensed medical practitioner.

Information for Patients:

Patients should discontinue the use of Selenium Sulfide 2.3% Shampoo if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes.

Carcinogenesis, Mutagenesis and Impairment of Fertility:

Dermal application of 25% and 50% solutions of 2.5% selenium sulfide lotion on mice over an 88-week period indicated no carcinogenic effects. Studies on reproduction and fertility also have not been performed.

Pregnancy:** Category C.**

Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

Nursing Mothers:

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

Pediatric use:

Safety and effectiveness in children under the age of 12 years have not been established.

OVERDOSAGE SECTION

LOINC: 34088-5Updated: 4/1/2021

OVERDOSAGE:

There are no documented reports of serious toxicity in humans resulting from acute ingestion of this product. However, acute toxicity studies in animals suggest that ingestion of large amounts could result in potential human toxicity. Evacuation of the stomach contents should be considered in cases of acute oral ingestion.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 4/1/2021

DOSAGE AND ADMINISTRATION:

For seborrheic dermatitis and dandruff: Wet skin and apply to areas to be cleansed. Massage gently into the skin working into a full lather. Rinse thoroughly and pat dry. Generally, two applications each week for two weeks will control symptoms. Subsequently, shampoo may be used less frequently, or as directed by a licensed medical practitioner. It should not be applied more frequently than necessary to maintain control.

For tinea versicolor: Wet skin and apply to areas to be cleansed. Massage gently into the skin working into a full lather. Allow product to remain on skin for ten minutes, then rinse thoroughly and pat dry. Repeat procedure once a day for seven days, or as directed by a licensed medical practitioner.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 4/1/2021

HOW SUPPLIED:

Selenium Sulfide 2.3% Shampoo is supplied in a 6 fl. oz. (180 mL) bottle, NDC 42494-336-06.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 4/1/2021

​STORAGE:

Store at 20-25°C (68-77°F); excursions permitted between 15° and 30°C (59° and 86°F). See USP Controlled Room Temperature.

Protect from freezing and excessive heat. Keep bottle tightly closed.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product has not been evaluated for therapeutic equivalence.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.